SINGULAR HEALTH GROUP LTD — Board/Management Information 2021

Sep 1, 2021

==> picture [596 x 87] intentionally omitted <==

Singular Health Group Ltd: SHG

ASX Announcement

2 September 2021

Advisory Board appointment of Professor Jonathan Clark AM

2 September 2021 – Singular Health Group Ltd (ASX: SHG), an Australian-based medical technology company is excited to announce the first appointment to its newly formed advisory Board, well-renowned reconstructive surgeon Prof. Jonathan Clark AM.

In line with the Company’s vision of Developing Better Health Literacy, which spans improving patient education through to the design and manufacture of patient-specific surgical implants, Singular Health is pleased to announce the formation of an advisory Board.

The advisory Board will consist of key opinion leaders with a broad cross-section of academic, commercial, and crucially, clinical experience who will provide technical and clinical advice to guide the development, commercialisation and integration of Singular’s medical software solutions into standard medical workflows.

The right combination of academic, commercial and clinical expertise is hard to find and Singular Health is very pleased to announce the appointment of Prof. Jonathan Clark AM. With over 280 peer-reviewed academic publications, covering facial construction, oral cancers and patient education, in addition to his roles as a consultant reconstructive surgeon at Chris O’Brien Lifehouse and Royal Prince Alfred Hospital, Prof. Clark is the ideal candidate as the first Advisory Board Member.

Awarded a Member of the Order of Australia (AM) in 2019 for his contribution to head and neck surgery, Jonathan is the Chair of Head and Neck Cancer Reconstruction at the University of Sydney, Director of Translational Research at the Royal Prince Alfred Institute of Academic Surgery, a founding member of the Sydney Facial Nerve Service and former chair of Head and Neck Cancer Australia, a patient education website for head and neck patients.

Prof. Jonathan Clark, Founding Advisory Board Member, said:

“This is an exciting opportunity to work with Singular Health in the area of digital planning for surgical applications. I believe that Scan to Surgery[TM] has the potential to revolutionise the interaction between surgeons, planning software, and design engineers by incorporating VR and streamlining the segmentation of DICOM data from CT images.”

Thomas Hanly, Singular Health’s Chief Executive Officer, said:

“I’m exceptionally pleased to announce the formation of our advisory board and to welcome Professor Clark as our first Advisory Board Member. His reputation in the patient-specific reconstructive surgical space is second to none and we look forward to applying his unique insights and clinical experience to the product development and commercialisation of our Scan to Surgery[ TM] initiative.”

==> picture [596 x 88] intentionally omitted <==

==> picture [154 x 43] intentionally omitted <==

In accordance with the terms of his engagement the Company will issue Prof. Clark with 250,000 unlisted options in the Company vesting twelve months from the date of his appointment to the advisory Board, with an exercise price of $0.30 and an expiry of three years.

Authorised for release by the Board of Directors.

Ends

For further information contact

Investors	Corporate
James Hill +61 413 825 646 jhill@singular.health	Steven Wood Company Secretary + 61 8 9322 7600

About Singular Health:

Founded in 2017, Singular Health is a medical technology company that has developed and commercialised the proprietary Volumetric Rendering Platform (“VRP”) for the 3D & VR visualisation of anatomy using standard radiological imagery.

Singular Health is committed to developing technologies that provides patients and practitioners alike with access to personalised, enhanced medical data to inform better health decisions and is currently developing and deploying software products that are built upon the proprietary VRP on a global scale through a direct-to-consumer Software-as-aService (“SaaS”) model.

About Scan to Surgery:

Scan to Surgery[TM] is a disruptive technology driven process that revolutionises the planning and execution of surgical procedures, reducing cost and improving patient outcomes. Built on the backbone of MFTP, incorporating 3D/VR scan review with virtual surgical planning software and utilising local additive manufacturing facilities, Scan to Surgery[TM] aims to rapidly deliver patient-specific solutions.

==> picture [594 x 30] intentionally omitted <==

ASX: SHG | www.singular.health

2